Home NDC 60505-2806-07 NDC 60505-2806-07 - Carbamazepine This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 60505-2806
Requested NDC 60505-2806-07
Package NDCs from labels 60505-2806-3, 60505-2806-7, 60505-2806-8, 60505-2806-07
Manufacturer Apotex Corp. | Apotex Inc.
Effective date 2026-09-10
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-2806-3 Carbamazepine 30 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 30 15 60505-2806-7 Carbamazepine 120 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 120 15 60505-2806-8 Carbamazepine 1000 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 1000 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-2806 CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 14 Current NDC, Legacy NDC, 3 package rows 20240922_e91f9de3-3fdd-0a6b-71ce-53a2cc142816.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 ETHYLCELLULOSE (7 MPA.S) INACTIVE INGREDIENT H3UP11403C CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 GELATIN INACTIVE INGREDIENT 2G86QN327L CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] 3
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 137 · 2,725 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.